RAPT Q2 2022 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RAPTRAPT Therapeutics, Inc.

$959M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$886,000+2.0% YoY

Gross Profit

$886,000100.0% margin

Operating Income

-$19M-2134.2% margin

Net Income

-$19M-2165.2% margin

EPS (Diluted)

$-4.93

QoQ Revenue Growth

+38.2%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$16M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$222M

Total Liabilities

$20M

Stockholders' Equity

$202M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$886,000	$869,000	+2.0%
Gross Profit	$886,000	$869,000	+2.0%
Operating Income	-$19M	-$16M	-17.6%
Net Income	-$19M	-$16M	-19.1%